Comparisons of Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) and Hospital-Associated MSRA Infections in Sacramento, California
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) has long been a common pathogen in healthcare facilities, but in the past decade, it has emerged as a problematic pathogen in the community setting as well. A retrospective case series study of patients from whom MRSA was isolated from December 1, 2003, through May 31, 2004, was conducted at the University of California, Davis, Medical Center. Patient data were collected from electronic medical records and traditional chart reviews to determine whether MRSA acquisition was likely to have been in the community or in the hospital. Antimicrobial susceptibility testing and pulsed-field gel electrophoresis (PFGE) were performed for all confirmed isolates. Skin and soft tissue were the most common infection sites for all MRSA patients. Among the 283 MRSA infections, 127 (44.9%) were defined as community-associated (CA)-MRSA. Ninety-six percent of the CA-MRSA isolates were susceptible to clindamycin. Double-disk diffusion tests were performed to examine inducible clindamycin resistance by erythromycin induction on both CA and hospital-associated (HA) clindamycin-susceptible and erythromycin-resistant isolates. Ten percent (17 of 183) were positive. Most CA-MRSA isolates were identified by PFGE as a unique strain, genotype USA300, which was not genetically related to the predominant genotype, USA100, in the HA-MRSA isolates. Injecting drug users accounted for 49% of CA-MRSA infections but only 19% of the HA-MRSA infections (odds ratio, 4.2; 95% confidence interval, 2.4 to 7.4). Our study shows that a single clone of CA-MRSA accounts for the majority of infections. This strain originated in the community and is not related to MRSA strains from healthcare settings. Injecting drug users could be a major reservoir for CA-MRSA transmission.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A recent upsurge in skin infections, abscesses, and more invasive infections among IDUs in North America has been reported in the literature (4, 12).”
From Methicillin-Resistant Staphylococcus aureus Nasal Carriage among Injection Drug Users: Six Years Later (2008) · cites this paper as [12]
In the citing paper
“the proportion of CA-MRSA in the total S. aureus found in our study (43%, 16/37) is lower than a hospital-based study in Atlanta, where 63% of S. aureus skin and soft tissue infections were due to CA-MRSA [13].”
From Community-associated methicillin-resistant Staphylococcus aureus is prevalent in wounds of community-based injection drug users (2010) · cites this paper as [13]
In the citing paper
“This novel strain has previously been recognized as a major cause of infections in a high-risk population such as IDUs (11, 12).”
From Methicillin-Resistant Staphylococcus aureus Nasal Carriage among Injection Drug Users: Six Years Later (2008) · cites this paper as [12]
Citations
Cites
Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H., & Swaminathan, B. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.9.2233-2239.1995 · Cited by 8,204
Naimi, T. S. (2003) · JAMA · doi:10.1001/jama.290.22.2976 · Cited by 1,688
"Celbenin" - resistant Staphylococci
Jevons, M. P. (1961) · BMJ · doi:10.1136/bmj.1.5219.124-a · Cited by 1,680
Methicillin-Resistant Staphylococcus aureus
Brumfitt, W., & Hamilton-Miller, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905043201806 · Cited by 934
The Major Medical Complications of Heroin Addiction
LOURIA, D. B., HENSLE, T., & ROSE, J. (1967) · Annals of Internal Medicine · doi:10.7326/0003-4819-67-1-1 · Cited by 615
Barrett, F. F., McGehee, R. F., & Finland, M. (1968) · New England Journal of Medicine · doi:10.1056/nejm196808292790901 · Cited by 512
Naimi, T. S., LeDell, K. H., Boxrud, D. J., Groom, A. V., Steward, C. D., Johnson, S. K., Besser, J. M., O’Boyle, C., Danila, R. N., Cheek, J. E., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/322693 · Cited by 369
Groom, A. V. (2001) · JAMA · doi:10.1001/jama.286.10.1201 · Cited by 360
SARAVOLATZ, L. D., MARKOWITZ, N., ARKING, L., POHLOD, D., & FISHER, E. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-1-11 · Cited by 355
Fey, P. D., Saïd-Salim, B., Rupp, M. E., Hinrichs, S. H., Boxrud, D. J., Davis, C. C., Kreiswirth, B. N., & Schlievert, P. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.196-203.2003 · Cited by 352
Siberry, G. K., Tekle, T., Carroll, K., & Dick, J. (2003) · Clinical Infectious Diseases · doi:10.1086/377501 · Cited by 343
Binswanger, I. A., Kral, A. H., Bluthenthal, R. N., Rybold, D. J., & Edlin, B. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313703 · Cited by 300
Charlebois, E. D., Bangsberg, D. R., Moss, N. J., Moore, M. R., Moss, A. R., Chambers, H. F., & Perdreau-Remington, F. (2002) · Clinical Infectious Diseases · doi:10.1086/338069 · Cited by 245 · cited 2×
“Although some investigators excluded IDUs as subjects (cases) for studying CA-MRSA infection (14, 19), one study (9) conducted in San Francisco indicated that injecting drug use may be responsible for increasing MRSA colonization in the urban poor community.”
Result(1999) · Archives of Dermatology · doi:10.1001/archderm.135.12.1566 · Cited by 209
Cockerill, F. R. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540250046030 · Cited by 201
Levin, T. P., Suh, B., Axelrod, P. I., Truant, A. L., & Fekete, T. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1222-1224.2005 · Cited by 180
Summanen, P. H., Talan, D. A., Strong, C., McTeague, M., Bennion, R., Thompson, J. E., Väisänen, M.-L., Moran, G., Winer, M., & Finegold, S. M. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.supplement_2.s279 · Cited by 177
Community-Acquired Methicillin-Resistant Staphylococcus aureus in Southern New England Children
Dietrich, D. W., Auld, D. B., & Mermel, L. A. (2004) · Pediatrics · doi:10.1542/peds.113.4.e347 · Cited by 149
Baggett, H. C., Hennessy, T. W., Leman, R., Hamlin, C., Bruden, D., Reasonover, A., Martinez, P., & Butler, J. C. (2003) · Infection Control & Hospital Epidemiology · doi:10.1086/502221 · Cited by 143
Maguire, G. P., Arthur, A. D., Boustead, P. J., Dwyer, B., & Currie, B. J. (1998) · Journal of Hospital Infection · doi:10.1016/s0195-6701(98)90076-7 · Cited by 100
Soft Tissue Infections Among Injection Drug Users--San Francisco, California, 1996-2000
(2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.21.2707 · Cited by 58
Bergstein, J. M., Baker, E. J., Aprahamian, C. J., Schein, M., & Wittmann, D. H. (1995) · PubMed · Cited by 53
Diep, B. A., Perdreau-Remington, F., & Sensabaugh, G. F. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.10.4559-4564.2003 · Cited by 48
Schnall, S. B., Holtom, P. D., & Lilley, J. C. (1994) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199410000-00012 · Cited by 28 · cited 2×
“It has been well documented (4, 22) that skin and soft tissue infections, such as abscesses and cellulitis, are directly related to injecting drug use.”
Background
Cited by
David, M. Z., & Daum, R. S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00081-09 · Cited by 1,972
Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology
Lakhundi, S., & Zhang, K. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00020-18 · Cited by 1,637
Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era
DeLeo, F. R., & Chambers, H. F. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38226 · Cited by 512
Miller, L. G., & Diep, B. A. (2008) · Clinical Infectious Diseases · doi:10.1086/526773 · Cited by 318
Liu, C., Graber, C. J., Karr, M., Diep, B. A., Basuino, L., Schwartz, B. S., Enright, M. C., O’Hanlon, S. J., Thomas, J. C., Perdreau‐Remington, F., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/587893 · Cited by 205
Metadata
- Authors
- Huang, H., Flynn, N. M., King, J. H., Monchaud, C., Morita, M., & Cohen, S. H.
- Affiliations
- University of California Davis Medical Center (US)
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2006-07
- Volume
- 44
- Issue
- 7
- Pages
- 2423-2427
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- OpenAlex
- W2112226108
- Cited by
- 186
- References
- 27
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 1 · 2021: 4 · 2020: 10 · 2019: 6 · 2018: 13 · 2017: 6 · 2016: 14 · 2015: 17 · 2014: 10 · 2013: 11 · 2012: 12
- FWCI
- 9.09
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Keywords
- community-acquired MRSA, hospital-acquired MRSA, methicillin-resistant Staphylococcus aureus, clindamycin resistance, USA300, USA100, pulsed-field gel electrophoresis genotyping, people who inject drugs, skin and soft tissue infections, antimicrobial susceptibility, Sacramento
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Anti-Bacterial Agents, California, Clindamycin, Cross Infection, DNA, Bacterial, Erythromycin, Female, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Retrospective Studies, Staphylococcal Infections, Staphylococcus aureus, Substance Abuse, Intravenous, Methicillin Resistance, Electrophoresis, Gel, Pulsed-Field, Community-Acquired Infections, Molecular Epidemiology, Drug Resistance, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.